Open AccessEvidence of Specific Benzodiazepine Binding to Myometrial Membrane Preparations From Human Pregnant Uterus
Author(s) -
Fioretti P.,
Melis G. B.,
Gambacciani M.,
Galbani P.,
RoncaTestoni S.
Publication year - 1986
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016348609157356
Subject(s) - medicine , uterus , in utero , obstetrics , gynecology , pregnancy , endocrinology , fetus , biology , genetics
The muscle relaxant effect of benzodiazepines (BDZ) is widely held to be mediated at central as well as at peripheral level. in this study we report that crude membrane preparations from the myometrium of pregnant women possess binding sites for [ 3 H]‐RO 5–4864, specific ligand for the peripheral type of BDZ receptor. Scatchard analysis shows a high affinity binding site (K D = 3.1±1.2 nM) and a class of low affinity binding sites (K D >30 nM). Displacement experiments show that various BDZ are differently effective in inhibiting [ 3 H]‐RO 5–4864 binding: RO 5–4864 > diazepam > flunitrazepam > lorazepam > chlordiazepoxide. in conclusion, these data seem to demonstrate that human myometrium possesses specific binding sites of “peripheral type” for BDZ. It may be suggested that these binding sites are involved in mediating the myometrial relaxant effect exerted by BDZ. Thus, peripherally active BDZ could be used as tocolytic agents, avoiding BDZ central effects.